Press Releases

2010 | 2009 | 2008 | 2007 | 2006
DateTitle  
09/07/10Neuralstem Collaborator to Present Stroke Study Results at Stem Cell & Regenerative Medicine ConferenceDownload PDFPrinter Friendly Version
08/25/10Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell TrialDownload PDFPrinter Friendly Version
08/18/10Neuralstem Receives Confirmation of Patent Claims From United States Patent and Trademark OfficeDownload PDFPrinter Friendly Version
08/16/10Neuralstem Reports Second Quarter Financial Results and Provides Business & Clinical UpdateDownload PDFPrinter Friendly Version
06/30/10Neuralstem Completes $10 Million Registered Direct OfferingDownload PDFPrinter Friendly Version
06/25/10Neuralstem to Raise $10 Million in Registered Direct OfferingDownload PDFPrinter Friendly Version
06/04/10Neuralstem ALS Trial Principal Investigator To Speak At Brookings InstitutionDownload PDFPrinter Friendly Version
05/24/10Neuralstem Updates Clinical Trial ProgressDownload PDFPrinter Friendly Version
05/17/10Neuralstem, Inc. Reports First Quarter Financial Results and Provides Business UpdateDownload PDFPrinter Friendly Version
05/10/10Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine CongressDownload PDFPrinter Friendly Version
05/04/10CNN.com Health Features Neuralstem's Stem Cell TreatmentDownload PDFPrinter Friendly Version
04/30/10Neuralstem's ALS Stem Cell Treatment Featured on CNNDownload PDFPrinter Friendly Version
03/31/10Neuralstem Announces 2009 Financial Results, Provides UpdateDownload PDFPrinter Friendly Version
02/18/10Neuralstem Completes $5.25 Million FinancingDownload PDFPrinter Friendly Version
01/21/10Neuralstem Announces First Patient Treated in ALS Stem Cell TrialDownload PDFPrinter Friendly Version
12/18/09Neuralstem Receives Approval To Commence First ALS Stem Cell Trial at Emory ALS Center Printer Friendly Version
11/17/09Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update Printer Friendly Version
09/21/09Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial Printer Friendly Version
09/09/09Neuralstem Receives Notice of Patent Allowance Printer Friendly Version
08/19/09Neuralstem, Inc. Listing Compliance Plan Accepted by NYSE AMEX Printer Friendly Version
08/13/09Neuralstem, Inc. Reports Second Quarter Financial Results and Provides Business Update Printer Friendly Version
08/13/09Neuralstem, Inc. Discloses NYSE Amex Notice Printer Friendly Version
07/01/09Neuralstem Raises $1 Million in Registered Direct Offering Printer Friendly Version
06/24/09Neuralstem Enters into Agreement with China Medical University in Taiwan to Develop Stem Cell Stroke Treatment Printer Friendly Version
06/08/09Neuralstem CEO Guest on NPR's "Maryland Morning with Sheilah Kast" Today Printer Friendly Version
06/05/09Neuralstem Receives Non-Compliance Notice from NYSE Amex Printer Friendly Version
06/04/09Neuralstem Receives Patent Allowance for Compounds That Promote Neurogenesis Printer Friendly Version
05/15/09Neuralstem, Inc. Reports First Quarter Financial Results and Provides Business Update Printer Friendly Version
05/15/09Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents Printer Friendly Version
03/31/09Neuralstem, Inc. Provides 2008 Financial Results and Business Update Printer Friendly Version
03/09/09Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS Printer Friendly Version
02/20/09Neuralstem's ALS Trial on Clinical Hold Printer Friendly Version
02/12/09Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board Printer Friendly Version
02/02/09Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference Printer Friendly Version
01/26/09Neuralstem Receives Final Notice of Allowance for New Stem Cell Immortalization Technology Patent Printer Friendly Version
12/18/08Neuralstem Files FDA Application for First ALS Stem Cell Trial Printer Friendly Version
12/02/08Neuralstem Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials Printer Friendly Version
11/18/08Neuralstem Enters Collaborative Stem Cell Agreement For Huntington's Disease in Germany Printer Friendly Version
11/14/08Neuralstem Reports Third Quarter Financial Results Printer Friendly Version
10/14/08Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology Printer Friendly Version
09/08/08Neuralstem CEO to Speak on ALS Panel at World Stem Cell Summit Printer Friendly Version
08/14/08Neuralstem Reports Second Quarter Financial Results and Highlights Printer Friendly Version
07/30/08Neuralstem Fills Key Product Development Position Printer Friendly Version
05/15/08Neuralstem Inc. Reports 2008 First Quarter Financial Results and Events Printer Friendly Version
05/12/08Neuralstem Responds to New StemCells, Inc. Lawsuit Printer Friendly Version
05/07/08Neuralstem Sues StemCells, Inc. Over New Patent Printer Friendly Version
05/06/08Neuralstem Goes to Court for Summary Judgment Against StemCells, Inc. Printer Friendly Version
04/28/08Neuralstem Announces Issuance of Core Technology Patent in Europe Printer Friendly Version
04/16/08Neuralstem to Sponsor the National Veterans Wheelchair Games, Hosted by the Paralyzed Veterans of America Printer Friendly Version
04/15/08Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents Printer Friendly Version
04/01/08Neuralstem to Present at Bio-Europe Spring Healthcare Conference, April 8, 2008 Printer Friendly Version
03/28/08Neuralstem Inc. Reports 2007 Year End Financial Results and Events Printer Friendly Version
02/20/08Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation Printer Friendly Version
12/17/07Neuralstem Enters Into Clinical Trial Research Agreement with University of Pennsylvania Printer Friendly Version
11/20/07Neuralstem Obtains UCSD Stem Cell Delivery System for Use in Spinal Cord Trials Printer Friendly Version
11/13/07Neuralstem Inc. Reports 2007 Third Quarter Financial Results and Events Printer Friendly Version
11/01/07Neuralstem to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference November 5, 2007 Printer Friendly Version
09/19/07Patent Office Rules in Neuralstem's Favor in Dispute with StemCells, Inc. Printer Friendly Version
08/30/07Neuralstem to Collaborate with University of Michigan ALS Clinic Printer Friendly Version
08/24/07Neuralstem Shares Accepted for Trading on Amex(R) Printer Friendly Version
06/26/07Patent Office Ruling in Favor of Neuralstem Leads to Stay of Stemcells Inc. Lawsuit Printer Friendly Version
05/30/07Neuralstem's Cells Restore Motor Function in Spinal Ischemia-Paralyzed Rats Printer Friendly Version
05/21/07Neuralstem Files Application for AMEX Listing Printer Friendly Version
05/14/07Neuralstem to Present at The Wall Street Analyst Forum May 22 Printer Friendly Version
04/24/07William C. Oldaker and Scott V. Ogilvie Join Neuralstem Board of Directors Printer Friendly Version
04/10/07John Conron Joins Neuralstem as Chief Financial Officer Printer Friendly Version
03/16/07Neuralstem Inc. Raises $5 Million in a Private Placement Printer Friendly Version
02/13/07Neuralstem Inc. Cells Survive and Become Neurons in Rats With Spinal Injuries, Study Reports Printer Friendly Version
01/11/07Neuralstem Licenses Out Compounds for Diabetes Treatment Printer Friendly Version
01/04/07NEURALSTEM (OTC Bulletin Board: NRLS) Receives Notice of Intention to Grant Core Patent From European Patent Office Printer Friendly Version
12/21/06Neuralstem (OTC Bulletin Board: NRLS) Shares Begin Trading Printer Friendly Version
11/01/06Neuralstem Teams with Local Alzheimer’s Association as Corporate Sponsor  Printer Friendly Version
10/16/06NEURALSTEM STEM CELLS EXTEND LIFE OF RATS  Printer Friendly Version
10/16/06Stem cells delay paralyzing disease Printer Friendly Version
10/15/06Human Stem Cells Help Rats to Fend Off Lou Gehrig's Disease Printer Friendly Version
08/04/06NeuralStem CEO, I.R. Garr Quoted in Baltimore Sun Printer Friendly Version
07/18/06US PATENT OFFICE UPHOLDS NEURALSTEM PATENT Printer Friendly Version